利用增强胸部CT图像的深度学习模型预测非小细胞肺癌患者的PD-L1表达
回顾性收集125例非小细胞肺癌患者的术前增强胸部CT图像和PD-L1免疫组化结果,以PD-L1表达<1%为阴性、≥1%为阳性,构建并验证结合深度学习特征与临床病理因素的深度学习影像组学模型(DLRM)。DLRM在训练集和验证集的AUC均为0.804,验证集IDI分析显示DLRM诊断准确率优于DLS(0.0028,p<0.05),DCA显示DLRM较DLS具有更多净获益;作者结论认为该模型可作为无创诊断工具区分NSCLC患者的PD-L1表达。
要点
- DLRM在训练集AUC为0.804(95%CI 0.697-0.911),验证集AUC为0.804(95%CI 0.679-0.929)。
- 验证集IDI分析显示DLRM诊断准确率优于DLS(0.0028,p<0.05)。
- DCA显示DLRM较DLS具有更多净获益。
核心结论
- 基于增强胸部CT图像构建的DLRM可作为无创诊断工具区分NSCLC患者的PD-L1表达。
研究设计与样本
- 回顾性研究,收集125例NSCLC患者的术前增强胸部CT图像和PD-L1免疫组化结果,以PD-L1表达<1%为阴性、≥1%为阳性,训练并验证结合卷积神经网络深度学习特征与临床病理因素的DLRM。
关键影像表现/征象
- DLS和肿瘤分期被DLRM识别为PD-L1表达的独立预测因素。
诊断标准与关键数值
- PD-L1表达<1%定义为阴性,≥1%定义为阳性。
- DLRM训练集AUC为0.804(95%CI 0.697-0.911)。
- DLRM验证集AUC为0.804(95%CI 0.679-0.929)。
- 验证集IDI分析显示DLRM诊断准确率优于DLS(0.0028,p<0.05)。
- DCA显示DLRM较DLS具有更多净获益。
临床应用与阅片要点
- 作者结论认为该DLRM可作为无创诊断工具区分NSCLC患者的PD-L1表达。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To develop a deep-learning model using contrast-enhanced chest computed tomography (CT) images to predict programmed death-ligand 1 (PD-L1) expression in patients with non-small-cell lung cancer (NSCLC).
MATERIALS AND METHODS: Preoperative enhanced chest CT images and immunohistochemistry results for PD-L1 expression (<1% and ≥1% were defined as negative and positive, respectively) were collected retrospectively from 125 NSCLC patients to train and validate a deep-learning radiomics model (DLRM) for the prediction of PD-L1 expression in tumours. The DLRM was developed by combining the deep-learning signature (DLS) obtained from a convolutional neural network and clinicopathological factors. The indexes of the area under the curve (AUC), integrated discrimination improvement (IDI), and decision curve analysis (DCA) were used to evaluate the efficiency of the DLRM.
RESULTS: DLS and tumour stage were identified as independent predictors of PD-L1 expression by the DLRM. The AUCs of the DLRM were 0.804 (95% confidence interval: 0.697-0.911) and 0.804 (95% confidence interval: 0.679-0.929) in the training and validation cohorts, respectively. IDI analysis showed the DLRM had better diagnostic accuracy than DLS (0.0028 [p<0.05]) in the validation cohort. Additionally, DCA revealed that the DLRM had more net benefit than the DLS for clinical utility.
CONCLUSION: The proposed DLRM using enhanced chest CT images could function as a non-invasive diagnostic tool to differentiate PD-L1 expression in NSCLC patients.
引用
- Liu PM, Feng B, Shi JF, et al. A deep-learning model using enhanced chest CT images to predict PD-L1 expression in non-small-cell lung cancer patients. Clin Radiol. 2023. PMID: 37460338. doi:10.1016/j.crad.2023.05.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。